David Kim

David Kim

Auto-generated profile, based on publicly available information

David Kim

Department of Pathology and Laboratory Medicine Memorial Sloan Kettering Cancer Center New York New York USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 June 2020 in Laboratory Investigation
Verified
Journal Article
Closed access
PDF file
MHMatthew G. Hanna
Matthew G. Hanna
VRVictor E. Reuter
Victor E. Reuter
OAOrly Ardon
Orly Ardon
DKDavid Kim
David Kim
SSSahussapont Joseph Sirintrapun
Sahussapont Joseph Sirintrapun
MHMeera Hameed
Meera Hameed

8 December 2022 in JCI Insight
Verified
Journal Article
Open access
PDF file
JGJacques Greenberg
Jacques Greenberg
JLJessica Limberg
Jessica Limberg
AVAkanksha Verma
Akanksha Verma
DKDavid Kim
David Kim
XCXiang Chen
Xiang Chen
IMIrene M. Min
Irene M. Min
Pancreatic neuroendocrine tumors (PNETs) are malignancies arising from the islets of Langerhans. Therapeutic options are limited for the over 50% of patients who present with metastatic disease. We aimed to identify mechanisms to remodel the PNET tumor microenvironment (TME) to ultimately enhance susceptibility to immunotherapy. The TMEs of localized and metastatic PNETs were investigated using an approach that combines RNA-Seq, cancer and T cell profiling, and pharmacologic perturbations. RNA-Seq analysis indicated that the primary tumors of metastatic PNETs showed significant activation of inflammatory and immune-related pathways. We determined that metastatic PNETs featured increased numbers of tumor-infiltrating T cells compared with localized tumors. T cells isolated from both localized and metastatic PNETs showed evidence of recruitment and antigen-dependent activation, suggestive of an immune-permissive microenvironment. A computational analysis suggested that vorinostat, a histone deacetylase inhibitor, may perturb the transcriptomic signature of metastatic PNETs. Treatment of PNET cell lines with vorinostat increased chemokine CCR5 expression by NF-κB activation. Vorinostat treatment of patient-derived metastatic PNET tissues augmented recruitment of autologous T cells, and this augmentation was substantiated in a mouse model of PNET. Pharmacologic induction of chemokine expression may represent a promising approach for enhancing the immunogenicity of metastatic PNET TMEs.

16 April 2024 in Journal of the American Society of Cytopathology
Verified
Journal Article
Open access
DKDavid Kim
David Kim
MTMichael J. Thrall
Michael J. Thrall
PMPamela Michelow
Pamela Michelow
Fernando SchmittFernando Schmitt
Fernando Schmitt
Philippe VielhPhilippe Vielh
Philippe Vielh
ZLZaibo Li
Zaibo Li
The integration of whole slide imaging (WSI) and artificial intelligence (AI) with digital cytology has been growing gradually. Therefore, there is a need to evaluate the current state of digital cytology. This study aimed to determine the current landscape of digital cytology via a survey conducted as part of the American Society of Cytopathology (ASC) Digital Cytology White Paper Task Force. A survey with 43 questions pertaining to the current practices and experiences of WSI and AI in both surgical pathology and cytology was created. The survey was sent to members of the ASC, the International Academy of Cytology (IAC), and the Papanicolaou Society of Cytopathology (PSC). Responses were recorded and analyzed. In total, 327 individuals participated in the survey, spanning a diverse array of practice settings, roles, and experiences around the globe. The majority of responses indicated there was routine scanning of surgical pathology slides (n = 134; 61%) with fewer respondents scanning cytology slides (n = 150; 46%). The primary challenge for surgical WSI is the need for faster scanning and cost minimization, whereas image quality is the top issue for cytology WSI. AI tools are not widely utilized, with only 16% of participants using AI for surgical pathology samples and 13% for cytology practice. Utilization of digital pathology is limited in cytology laboratories as compared to surgical pathology. However, as more laboratories are willing to implement digital cytology in the near future, the establishment of practical clinical guidelines is needed.

18 May 2022 in Cancer Cytopathology
Verified
Journal Article
Closed access
DKDavid Kim
David Kim
RBRobert Burkhardt
Robert Burkhardt
SASusan A. Alperstein
Susan A. Alperstein
HGHamza N. Gokozan
Hamza N. Gokozan
AGAbha Goyal
Abha Goyal
MSMomin T. Siddiqui
Momin T. Siddiqui

24 January 2020 in Cancer Cytopathology
Verified
Journal Article
Closed access
PDF file
DKDavid Kim
David Kim
KVKartik Viswanathan
Kartik Viswanathan
AGAbha Goyal
Abha Goyal
RRRema Rao
Rema Rao

26 January 2019 in Diagnostic Microbiology and Infectious Disease
Verified
Journal Article
Closed access
RMReed Magleby
Reed Magleby
DBDavid A. Bemis
David A. Bemis
DKDavid Kim
David Kim
KCKaren C. Carroll
Karen C. Carroll
MCMariana Castanheira
Mariana Castanheira
LWLars F. Westblade
Lars F. Westblade